Dyne Therapeutics to present at Jefferies Global Healthcare Conference on Nov 16, 2026

Dyne Therapeutics, a clinical-stage biotech company focused on neuromuscular diseases, will participate in the Jefferies Global Healthcare Conference on November 16, 2026. The company's management will hold a fireside chat in London, which will be webcast live and available for replay. Dyne is advancing treatments for diseases like Duchenne muscular dystrophy and myotonic dystrophy type 1, aiming to improve patient function. This event provides an opportunity for investors to learn about Dyne's progress and future plans.

Dyne Therapeutics shares are trading at USD 17.52 on Pluang as of Nov 11, 2026 19:11 WIB, down 2.23% for the day. This price is closer to the 52-week low of USD 14.25 than the high of USD 26.78, indicating the stock remains well below its peak over the past year. The balanced 50% sell and 50% buy order activity suggests mixed investor sentiment around the company’s upcoming conference participation.